中利集團(002309.SZ):實控人王柏興質押的3500萬股被司法標記
格隆匯7月7日丨中利集團(002309.SZ)公佈,公司於近日獲悉,公司控股股東、實際控制人王柏興質押的公司股票被司法標記,此次被司法標記的基本情況:

注:王柏興所持公司股份3500萬股已在中國證券登記結算有限責任公司深圳分公司辦理了相關質押登記手續,質押登記日為2016年7月18日,質押期限自2016年7月18日起至向中國證券登記結算有限責任公司深圳分公司辦理解除質押為止。
公司控股股東、實際控制人王柏興及其一致行動人累計質押股份數量為23691.97萬股,佔其所持公司股份數量比例超過80%,請投資者注意相關風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.